Neoadjuvant chemotherapy less commonly used in breast cancer

Published Date: 02 Mar 2023

Most women will have breast cancer surgery first if the initial consultation is with a surgeon. This study has been published as a preprint and has not yet been peer-reviewed.

Read Full News

Latest News

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

MRI Sharpens Prostate Cancer Risk Stratification

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Minimally Invasive Ablation Can Treat Small Kidney Tumors

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 Delays Progression in Prostate Cancer

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

Does ART Match ALND After Neoadjuvant Breast Cancer Therapy?

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

BC Rate Low in BRCA Carriers After Risk-Reducing Mastectomy

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

News All Time

Nerve Wrap Seen Speeding Erectile Recovery Post-Prostatectomy

Dehydrated human amniotic membrane appears promising in observational findings from a large dataset.

Stryker Cyberattack Delays Surgeries for Some Patients, Bloomberg News Reports

A cyberattack against medical device maker Stryker last ⁠week has delayed surgeries for some patients, Bloomberg News ⁠reported on Wednesday.

New Strategies Drive Success in Crohn’s Disease Care

In the management of Crohn’s disease, a key objective — preserving the bowel by reducing the need for multiple resections — is gaining ground.

Analysis-Middle East War Disrupts Pharma Air Routes, Risks Cancer Drugs Supply

War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration...

Does ADT Improve Survival After PORT in Prostate Cancer?

A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

Exercise and Lifestyle Help Manage Ankylosing Spondylitis

Evidence shows supervised exercise programs significantly improve function and quality of life in patients with axial spondyloarthritis.

Can Local Therapy Extend Life in Metastatic Breast Cancer?

For some women with de novo metastatic breast cancer, surgical resection of the primary tumor is associated with longer survival.

How to Talk to Your Patients About Exercise and Pain

Some are afraid to move if it hurts. Some push too hard. Everyone agrees that exercise reduces chronic pain and enhances health — but how do you keep patients on track?

CEM Matches MRI for Nipple-Areola Analysis in Breast Cancer

Contrast-enhanced mammography offers a reliable alternative to MRI in evaluating nipple-areola complex involvement in patients with breast cancer before surgery.

PSA May Predict Hormone Therapy Benefit Post-Prostatectomy

A meta-analysis seeks to determine if adding hormone therapy to radiotherapy after prostatectomy improves overall survival.

Life in the Endless Scroll: What We're Losing

What looks like harmless screen time may be altering emotional resilience and cognitive focus in young users.

MRI-Guided Chemotherapy Improves Survival in Breast Cancer

MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.

Doc Pay Boosted $400 Million With New Medicare Billing Code

A new JAMA study shows that a new Medicare billing code may have benefited specialists more than the primary care physicians it was designed to help most.

NICE Backs Paperclip-Sized Sensor for Heart Failure Care

The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

Dual Biologics May End Daily Pills Post-Kidney Transplant

A novel dual biologic regimen combining dazodalibep and belatacept is well tolerated and could enable more than half the kidney transplant recipients to avoid broader metabolic pathway inhibitors.

Which Imaging Method Best Detects At-Risk MASH?

Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based scoring system performing best among commonly used methods.

Recommended News For You

More People Than Previously Believed Have Schizophrenia.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Study finds higher breast cancer rates in areas with more air pollution

New imaging guidelines for head and neck cancers, a step toward practice change

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

Recommended Articles For You

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making 

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health 

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

5.

Microplastics can cause malignant changes in lung cells

1.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

2.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

3.

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management

4.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

5.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Current Scenario of Cancer- The Incidence of Cancer in Men

4.

Navigating the Complexities of Ph Negative ALL - Part I

5.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot